UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:MedicinalProductDefinition ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "Oxascand-10mg-Tablet-SE-IS-MPD"] ; #
fhir:meta [
( fhir:profile [
fhir:v "http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"^^xsd:anyURI ;
fhir:link <http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition> ] )
] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition Oxascand-10mg-Tablet-SE-IS-MPD</b></p><a name=\"Oxascand-10mg-Tablet-SE-IS-MPD\"> </a><a name=\"hcOxascand-10mg-Tablet-SE-IS-MPD\"> </a><a name=\"hcOxascand-10mg-Tablet-SE-IS-MPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100001594-00010743, <code>http://ema.europa.eu/fhir/eurdId</code>/2234</p><p><b>domain</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}\">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073664}\">Tablet</span></p><p><b>indication</b>: </p><div><p>Oxascand påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Oxascand användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.</p>\n</div><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 100000072085}\">Medicinal product subject to special medical prescription</span></p><p><b>classification</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000116677 100000093533}\">N05BA04</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Oxascand 10 mg Tablett</p><blockquote><p><b>part</b></p><p><b>part</b>: Oxascand</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000002}\">Invented name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 10 mg</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}\">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Tablett</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}\">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 sv}\">Swedish</span></td></tr></table></blockquote></div>"
] ; #
fhir:identifier ( [
fhir:system [ fhir:v "http://ema.europa.eu/fhir/mpId"^^xsd:anyURI ] ;
fhir:value [ fhir:v "SE-100001594-00010743" ]
] [
fhir:system [ fhir:v "http://ema.europa.eu/fhir/eurdId"^^xsd:anyURI ] ;
fhir:value [ fhir:v "2234" ]
] ) ; #
fhir:domain [
( fhir:coding [
fhir:system [ fhir:v "https://spor.ema.europa.eu/v1/lists/100000000004"^^xsd:anyURI ] ;
fhir:code [ fhir:v "100000000012" ] ;
fhir:display [ fhir:v "Human use" ] ] )
] ; #
fhir:status [
( fhir:coding [
fhir:system [ fhir:v "https://spor.ema.europa.eu/v1/lists/200000005003"^^xsd:anyURI ] ;
fhir:code [ fhir:v "200000005004" ] ;
fhir:display [ fhir:v "Current" ] ] )
] ; #
fhir:combinedPharmaceuticalDoseForm [
( fhir:coding [
fhir:system [ fhir:v "https://spor.ema.europa.eu/v1/lists/200000000004"^^xsd:anyURI ] ;
fhir:code [ fhir:v "100000073664" ] ;
fhir:display [ fhir:v "Tablet" ] ] )
] ; #
fhir:indication [ fhir:v "Oxascand påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Oxascand användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk."] ; #
fhir:legalStatusOfSupply [
( fhir:coding [
fhir:system [ fhir:v "https://spor.ema.europa.eu/v1/lists/100000072051"^^xsd:anyURI ] ;
fhir:code [ fhir:v "100000072085" ] ;
fhir:display [ fhir:v "Medicinal product subject to special medical prescription" ] ] )
] ; #
fhir:classification ( [
( fhir:coding [
fhir:system [ fhir:v "https://spor.ema.europa.eu/v1/lists/100000116677"^^xsd:anyURI ] ;
fhir:code [ fhir:v "100000093533" ] ;
fhir:display [ fhir:v "N05BA04" ] ] )
] ) ; #
fhir:name ( [
fhir:productName [ fhir:v "Oxascand 10 mg Tablett" ] ;
( fhir:part [
fhir:part [ fhir:v "Oxascand" ] ;
fhir:type [
( fhir:coding [
fhir:system [ fhir:v "http://spor.ema.europa.eu/v1/lists/220000000000"^^xsd:anyURI ] ;
fhir:code [ fhir:v "220000000002" ] ;
fhir:display [ fhir:v "Invented name part" ] ] ) ] ] [
fhir:part [ fhir:v "10 mg" ] ;
fhir:type [
( fhir:coding [
fhir:system [ fhir:v "http://spor.ema.europa.eu/v1/lists/220000000000"^^xsd:anyURI ] ;
fhir:code [ fhir:v "220000000004" ] ;
fhir:display [ fhir:v "Strength part" ] ] ) ] ] [
fhir:part [ fhir:v "Tablett" ] ;
fhir:type [
( fhir:coding [
fhir:system [ fhir:v "http://spor.ema.europa.eu/v1/lists/220000000000"^^xsd:anyURI ] ;
fhir:code [ fhir:v "220000000005" ] ;
fhir:display [ fhir:v "Pharmaceutical dose form part" ] ] ) ] ] ) ;
( fhir:usage [
fhir:country [
( fhir:coding [
fhir:system [ fhir:v "https://spor.ema.europa.eu/v1/lists/100000000002"^^xsd:anyURI ] ;
fhir:code [ fhir:v "100000000535" ] ;
fhir:display [ fhir:v "Kingdom of Sweden" ] ] ) ] ;
fhir:language [
( fhir:coding [
fhir:system [ fhir:v "urn:ietf:bcp:47"^^xsd:anyURI ] ;
fhir:code [ fhir:v "sv" ] ;
fhir:display [ fhir:v "Swedish" ] ] ) ] ] )
] ) . #
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
research and innovation programme under grant agreement No. 875299.